Medicare doesnt cover drugs used for weight loss, but Wegovy made the list because it is also approved to reduce major heart complications, according to the papers authors
This mechanism is distinct from how the medication controls blood sugar or promotes weight loss
Most people experience a significant reduction in hunger - which is the mechanism that drives weight loss
Its actions on GLP-1 and GIP receptors promote delayed gastric emptying and appetite control, offering a comprehensive approach to obesity research distinct from older GLP-1 agonists.
Most medical professionals recommend discussing timing with your prescribing provider rather than stopping abruptly, since discontinuing GLP-1 therapy can trigger rapid appetite rebound once you recover
Improvements in exercise tolerance, reduced shortness of breath, decreased swelling, lower NT-proBNP levels, and better echocardiogram results all suggest heart benefits from treatment